.A) Chemical structure of major cytosine modifications known to exist in eukaryotic RNA. B) Corresponding phosphoramidite monomerssynthesised in this work.
The synthesis of 2'-O-methyl-5-hydroxymethylcytidine (hm 5 Cm), 5-hydroxymethylcytidine (hm 5 C) and 5-formylcytidine (f 5 C) phosphoramidite monomers has been developed. Optimisation of mild post-synthetic deprotection conditions enabled the synthesis of RNA containing all four naturally occurring cytosine modifications (hm 5 Cm, hm 5 C, f 5 Cp lus 5-methylcytosine) . Given the considerable interesti nR NA modifications and epitranscriptomics, the availability of syntheticm onomers and RNAs containingt hese modifications will be valuable for elucidating their biological function(s).
Post-transcriptional chemical modifications in RNA are more diverse and complext han epigenetic modifications in DNA and in histones. So far more than 140 chemically distinct RNA modifications have been identifiedi nv ariouss pecies. The majority of these modifications involve methylation, of which 2' ribose sugar methylation is the most abundant. [1] These modifications were initially considered as static and stable marks; however, recent studies have revealed their dynamic nature and involvementi ni mportant gene-regulatory functions. [2] For instance, N 6 -methyladenosine (m 6 A), ap redominant internal modification in eukaryotic messenger RNA (mRNA), can be oxidatively convertedt oa denosine by demethylases such as fat mass and obesity-associated protein (FTO) and alkB homologue 5( ALKBH5). [3] This reversible adenosine methylation is proposed to be involved in RNA maturation, protein translation and gene expression. [4] 5-Methylcytidine (m 5 C) is another important methylated ribonucleoside that exists in transfer RNA (tRNAs), ribosomal RNA (rRNA), and in the untranslated regions of mRNAs. [2, 5] We and others have demonstrated that m 5 Cc an be oxidatively metabolisedt op roduce 5-hydroxymethylcytidine (hm 5 C) and 5-formylcytidine (f 5 C; Scheme 1). [6, 7] Additionally,i ti sp roposed that m 5 Ci se ssential for mRNA export and post-transcriptionalr egulation. [8] Significant enrichment of hm 5 Ci np olyadenylated RNA comparedt ot otal RNA furthers uggestst hat biosynthesis of hm 5 Cm ight be ap art of ad ynamic regulatory mechanism of RNA. [6b, 9] The f 5 Cm odification is prevalent at the wobble position of an anticodonl oop of mitochondrial methionine tRNA in many species, including humans.I tw as observed that f 5 Cp rovidesf lexibility to the loop and affords an ability to decode both AUG and AUA in translational initiation and elongation sites of mRNA. [10] Chemical labelling coupled with liquid chromatography-mass spectrometry (LC-MS) analysisr evealed the existence of 5-carboxycytidine (ca 5 C) in mousel iver tissue, albeit at av ery low concentration. [11] Recently,w ed iscovered the existence of 2'-Omethyl-5-hydroxymethylcytidine (hm 5 Cm), as econd methylated metabolite of m 5 C, in the RNA of higher organisms (Scheme 1). [12] The formation of hm 5 Cm from m 5 Cb ys tepwise oxidation via hm 5 Csupports the dynamic nature and complexity of these cytosine modifications in RNA. [12] [13] An efficient synthesis of oligonucleotides (ONs) containing these modifications is essential to elucidate the chemistry and function of RNA cytosine derivatives. For example, site-specific incorporation of these cytosine modifications into RNA will enable the development of sequencing methods to decode the modification [14] and also help identify the readerp roteins so ast ou nderstand the cellular functionsoft hesemodifications. [8] One phosphoramidite monomer used for the synthesis of m 5 C-containing RNA ONs is commercially available, and syntheseso ff 5 Ca nd hm 5 Cm onomersh ave been reported in the literature. [10, 15] We set out to develop as ynthesis of ah m 5 Cm monomer that would be compatible with solid-phase RNA ONs synthesis, whichh as not yet been described. In addition, the reported monomer for the synthesis of f 5 C-containing RNA ONs requires am ultistep synthesis with 2'-bis(2-acetoxyethoxy)methyl (ACE) orthoester and 5'-O-benzhydroxy-bis(trimethylsiloxy)silyl (BZH) protection. [10] One drawback of this monomer is the presence of af ree formyl group that is susceptible to the oxidation and nucleophilic attack encountered during ON assembly and post-synthetic resin cleavage, respectively. [10, 16] Consequently,m ultiple incorporations by using the existing f 5 Cp hosphoramidite are difficult, especiallyi nt he synthesis of longer oligomers or in combination with other cytosine modifications such as hm 5 Ca nd hm 5 Cm containing an ucleophilic moiety.T oo vercome these practical limitations, we designeda na lternative f 5 Cm onomer in which the reactive formyl group is appropriatelym asked. Riml and Micura reported the synthesis and incorporation of ah m 5 Cm onomer into RNA ONs;t heir route provides this monomer in a3%o verall yield in eight steps from 5-hydroxymethyluridine (hm 5 U), [15] which itself is obtained in at hree-step synthesis from uridine, and this brings the total number of steps to 11. [17] We therefore, at the same time, consideredt he development of af aster and more efficient route to this monomer.T he presenceo ft he 2'-hydroxy group makes the synthesis and incorporation of functionally modified ribonucleoside phosphoramidites particularly challenging compared to that of the analogous DNA phosphoramidite. [10, 15, 18] Moreover,a no rthogonal protection strategyd evelopedf or the synthesis of DNA ONs does not necessarily work for RNA due to its inherently more labile nature. [18a] Herein, we describe the development of phosphoramidite buildingb locks of hm 5 Cm, f 5 Ca nd hm 5 C( Scheme1)a nd demonstrate the incorporation of all thesec ytosine modifications into RNA ONs at severalp ositions and in severalc ombinations by solid-phase RNA synthesis.
To synthesise hm 5 Cm phosphoramidite 1,w ed ecided to protect the 5-hydroxymethyl with an acetyl group, whichi s compatible with the incorporationo fh m 5 Ci nto RNA ONs. [15] Startingw ith commerciallya vailable 2'-O-methyl-5-methyluridine (4), we protected the 5'-hydroxy group with a4 ,4'-dimethoxytrityl (DMT) and the 3'-hydroxy group with a tert-butyldimethylsilyl (TBS) group (Scheme2). [19] The DMT-and TBS-protected uridine, 6,w as then subjected to azobisisobutyronitrile (AIBN)-catalysed bromination of the 5-methylg roup by using N-bromosuccinimide (NBS). [20] The crude bromo derivative was treated with potassium acetate to yield the fully protected uridine analogue 7 in moderate yield. [19] The reaction of 7 with 2,4,6-triisopropylbenzenesulfonyl (TPS) chloride resulted in regioselectively O 4 -trisylated compound that was readily converted into cytidine analogue 8 upon ammonolysis. The exocyclic amino group wasa cetylated with acetic anhydride in pyridine to provide nucleoside 9.C leavage of the 3'-O-TBS group with TBAF and acetic acid in THF gave precursor 10.F inally,p hosphitylation of the 3'-hydroxy group with 2-cyanoethyl-N,N-diisopropylchloro-phosphoramidite (CEP-Cl) in the presence of N,N-diisopropylethylamine afforded phosphoramidite 1 in a 6.7 %overall yield in seven steps from 4. [19] In DNA synthesis, acetal chemistry has been successfully used to protect the formyl group. [21] To explore the analogous protection of f 5 Cf or RNA, we synthesised phosphoramidite buildingb lock 2 (Scheme 3). [19] Starting from 5-methyluridine (11), we protected the 3'-a nd 5'-hydroxy groups with di-tertbutylsilylene and subsequently protected the 2'-hydroxy group with TBS. [22] Nucleoside 12 was selectively brominated att he C5-methyl group, then acylationy ielded uridine-derivative 13 in good yield. Hydrolysis of 13 provided 5-hydroxymethyl derivative 14,w hich was then converted into aldehyde 15 by Dess-Martin periodinane (DMP) oxidation. [23] Next, the formyl group was protected as a1 ,3-dioxane by using propane-1,3diol in the presence of TiCl 4 ,a ccording to the procedure described for synthesising an analogous 2'-deoxy phosphoramidite. [21] Fully protected uridine analogue 16 was then treated with TPS-Cl, followed by ammonolysis to give cytidine analogue 17.T he exocyclica mino group was acetylated with acetic anhydride in pyridine to provide 18.
The 3',5 '-O-di-tert-butylsilylene group was selectively removedb yt reating 18 with HF·pyridine. Finally,5'-OH DMT protectiona nd subsequent phosphitylation yielded target monomer 2.S tartingf rom 5-methyluridine and following this tenstep route, we obtained monomer 2 in ag ood 10.5 %o verall yield (Scheme 3). [19] Comparedt ot he previously reported synthesis for an f 5 Cp hosphoramidite, we have significantly improvedt he overall yield and, more importantly,w eh ave now deployed af ormyl protectiveg roup. [10] We anticipated that this fully protected monomer would allow us to incorporate f 5 Ca tm ultiple positions in longer ONs and also in the combi-Scheme3.Synthesis of f 5 Cphosphoramidite 2. [19] a) (tBu) 2 Si(OTf) 2 ,TBS-Cl, imidazole,D MF,RT(91 %);b)NBS, AIBN, benzene, 80 8C; c) CH 3 CO 2 K, DMF,508C (64 %);d)K 2 CO 3 ,H 2 O, THF,RT(92 %);e)DMP,CH 2 Cl 2 ,08C!RT (77 %);f)propane-1,3-diol, triethyl orthoformate, TiCl 4 ,CH 2 Cl 2 ,08C(88 %);g)TPS-Cl, Et 3 N, DMAP, CH 2 Cl 2 ,RT; h) aq NH 3 ,THF,RT(67 %);i )Ac 2 O, pyridine,08C!RT (95 %);j )HF·pyridine, CH 2 Cl 2 ,08C( 95 %);k)DMT-Cl, DMAP, pyridine, RT (63 %);l)CEP-Cl, iPr 2 NEt, CH 2 Cl 2 ,RT(76 %).
Scheme2.Synthesis of hm 5 Cm phosphoramidite 1. [19] Next, we synthesised the hm 5 Cp hosphoramidite 3 (Scheme 4). During the synthesis of the previoust wo monomers, we noted that the methyl group of appropriately protected 5-methyluridine could be functionalised efficiently. Hence, we startedo ur synthesis by protecting the 5'-hydroxy group of 5-methyluridine (11)w ith DMT,t og ive 21,a nd protecting the 2'-a nd 3'-hydroxy groups with TBS. Conversion of the 5-methyl group of 22 into the 5-acetyloxymethyl group was the key step in this synthesis, and we achieved it by brominationa nd subsequent acylation. [19] From here onwardsw e followed the route reported by Riml et al. and obtained monomer 3 in eight steps with 6.4 %o verall yield (Scheme 4). [15, 19] During the preparation of this manuscript, the Micura group improved their initial synthesis and reported an alternative method, starting from cytidine, to obtained this monomer in eight steps with 9.2 %overall yield. [24] To evaluate the utility of our building blocks for obtaining ONs containing various modifications we synthesised as mall series of RNA ONs ( Figure 1A) . To further confirm the robustness of these monomers, we synthesised RNA 1-RNA 3, which each contain as ingle modification at three different positions, and RNA 4, which contains all four cytosine modifications. To ascertain the compatibility of these monomersi nt he presence of ab iochemical tag, we also performed the RNA ON synthesis on CPG solid support tethered to triethylene glycol (TEG)biotin. Modified phosphoramidites were incorporated into RNA ONs according to as tandard solid-phase RNA ON synthesis protocol. [25] Modifiedp hosphoramidite substrates 1-3 were incorporated with ac oupling time of 10 min, with 80-90 %c oupling efficiency,b ased on at rityl release assay.O ligonucleotides were cleaved from the solid support with 20 %e thanol in NH 4 OH. 2'-O-TBS deprotection was performed witha1:1m ixture of anhydrous DMSO and triethylamine trihydrofluoride. RNA 1a nd RNA 3w ere purifiedb yH PLC at this stage, whereas Scheme4.Synthesis of hm 5 Cp hosphoramidite 3. [19] [19] ChemBioChem 2017, 18,2236 -2241 www.chembiochem.org 2017 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim RNA 2a nd 4w ere each subjected to deprotection of the acetal moiety to revealt he formyl group. [19] Conditions previously used for the acetal deprotection of fdC in DNA led to only partial deprotection of the acetal group for RNA 2a nd RNA 4, along with precipitation of RNA. After screening several deprotection conditions, we found that treating RNA ON with 20 % aqueous acetic acid resultsi nc omplete and clean removal of the acetal group withoutc leavage of the RNA ( Figure S1 in the Supporting Information). The purity and integrity of all modified RNA ONs were confirmed by LC-MSa nalysis ( Figures 1, S1 and S2). [19] To further demonstrate,b eyond mass spectroscopy,t hat the modified ribonucleosides remainedi ntact upon RNA synthesis and deprotection,w ep erformed ap ost-synthetic chemical functionalisation of the RNA. Firstly,w es ubjected the RNA 2, which containsareactive formyl group,t on ucleophile addition with ethoxyamine hydrochloride at pH 5.0 in the presence of anisidine. [26] All three f 5 Cn ucleotides in RNA 2u ndergo facile addition of ethoxyamine, followed by elimination of water to form as table imine derivative, which we confirmed by LC-MS analysis ( Figure 2 ). [19, 26] Next, we performed the same reaction with RNAs 1a nd 3, and observed that both the RNA ONs remain unaltered. This experiment supports the functional integrity of these modifications in RNA.
In summary,w eh aved emonstrated the efficient syntheses of hm 5 Cm, hm 5 C, and f 5 Cb uildingb locks and the synthesis of RNA ONs containing these modificationsa tm ultiple positions in excellent yield and purity.T he availability of these monomers and the ability to prepare RNA oligomers with any combination, in desired positions, will be important for studying the function(s)o fc ytosine modificationsinb iology.
